Skip to search boxSkip to navigationSkip to main content

Cannabinoids in pediatrics

  • Christopher T. Campbell(corresponding author)
    ,
  • Marjorie Shaw Phillips
    ,
  • Kalen Manasco
*Corresponding author for this work
  • University of Florida
    ,
  • University of Georgia
    ,
  • Augusta University
Scholary Output:
Contribution to journal
Review article
Peer-review

Open access

Abstract

Despite its controversial nature, the use of medical marijuana and cannabis-derived medicinal products grows more popular with each passing year. As of November 2016, over 40 states have passed legislation regarding the use of either medical marijuana or cannabidiol products. Many providers have started encountering patients experimenting with cannabis products for a wide range of conditions. While the debate continues regarding these agents for both medicinal and recreational use in the general population, special consideration needs to be made for pediatric use. This review will deliver the history of marijuana use and legislation in the United States in addition to the currently available medical literature to equip pediatric health care providers with resources to provide patients and their parents the best recommendation for safe and appropriate use of cannabis-containing compounds.

Publication Information

Output type

Scholary Output:
Contribution to journal
Review article
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 176-185 (10 pages)

Journal (Volume, Issue Number)

Journal of Pediatric Pharmacology and Therapeutics (Volume 22, Issue 3)

Publication milestones

  • Published - 05/01/2017

Publication status

Published - 05/01/2017

ISSN

1551-6776

Publication IDs

  • Scopus: 85040966980

Publication metrics

Metrics

Scopus
citations
SciVal
FWCI
2.43
SciVal
Author count
3
SciVal
citations
30
SciVal
Paper percentile
93
SciVal
Top percentile
10
Fractional count
1
Fractional count
0.33
Fractional count
2
Fractional count
0.67
Fractional count
1
Fractional count
1

PlumX, opens in new tab

Citation count
69
Mentions
1
Captures
123
Social media
6

Funding Details

The authors declare no conflicts or financial interest in any product or service mentioned in the manuscript, including grants, equipment, medications, employment, gifts, and honoraria. Of note, both Augusta University (ClinicalTrials. gov Identifier: NCT02397863) and the University of Florida (ClinicalTrials.gov Identifier: NCT02461706) are sponsors of expanded access clinical trials of cannabidiol and drugresistant epilepsy in children.
FundersFunding numbers
UF
NCT02461706
Augusta University
NCT02397863